RxDoctor Payments Data

Joseph Franecki

Physician Assistant · Milwaukee, WINPI 1396378840

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Gilead accounts for 65.1% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $13,426, more than ten times the $773 reported in 2021. Among physician assistant clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,288in general payments, 2019–2025

Across 372 payments — averaging $73.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$18K
  • Viiv Healthcare Company$7K
  • Merck$734
  • Johnson & Johnson$404
  • AbbVie$258
  • AstraZeneca$248
  • plus $538 from 13 others

What the payments were for

  • Speaking & faculty fees$15,44057%
  • Travel & lodging$2,3549%
  • Food & beverage$9,47335%
  • Education$220%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,288 in reported general payments places this provider in the 95th percentile of 2,804 physician assistant providers in Wisconsin.

See all physician assistant providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala316$1,328,410
OdefseyEmtricitab/Rilpiviri/Tenof Ala41$151,241
GenvoyaElviteg/Cob/Emtri/Tenof Alafen12$55,369
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf11$51,876
PrezcobixDarunavir/Cobicistat11$31,485
TrulicityDulaglutide14$15,478
JanuviaSitagliptin Phosphate15$9,512
JardianceEmpagliflozin13$7,623
Fluticasone Propionate HfaFluticasone Propionate17$3,868
Albuterol Sulfate HfaAlbuterol Sulfate89$2,080
Omega-3 Acid Ethyl Esters15$889
Atorvastatin Calcium174$876
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$809
Amlodipine Besylate115$485
Gabapentin28$467

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya$17,752$1,383,779328 claims
Johnson & JohnsonPrezcobix$404$31,48511 claims
Lilly USA, LLCTrulicity$21$15,47814 claims
MerckJanuvia$734$9,51215 claims
Boehringer IngelheimJardiance$15$7,62313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,804 physician assistant providers in Wisconsin.

Other physician assistant in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →